Diamyd Medical AB (publ) (DMYD-B) — Capital Reinvestment Ratio
Latest as of November 2021:
2026.00x
Diamyd Medical AB (publ) (DMYD-B) has a Capital Reinvestment Ratio of 2026.00x as of November 2021, meaning it reinvests 2026% of its operating cash flow (Skr21.00K) in capital expenditures (Skr42.55 Million). See DMYD-B cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
2026.00x
Capex / Operating Cash Flow
Operating Cash Flow
Skr21.00K
SEK
Capital Expenditures
Skr42.55 Million
SEK
Data as of
Nov 2021
Most recent filing
Diamyd Medical AB (publ) Capital Reinvestment Ratio (2010–2020)
This chart tracks Diamyd Medical AB (publ)'s Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for Diamyd Medical AB (publ) (2010–2020)
Year-by-year Capital Reinvestment Ratio for Diamyd Medical AB (publ) from 2010 to 2020. For live market cap and broader valuation context, see Diamyd Medical AB (publ) (DMYD-B) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.12x | Skr16.88 Million | Skr1.98 Million | ▲ +3681.4% |
| 2010 | 0.00x | Skr225.77 Million | Skr700.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow